STOCK TITAN

Trust linked to Nuvalent (NUVL) files Form 144 to sell 1,650 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Nuvalent, Inc. insider-related trust plans modest stock sale under Rule 144. A Form 144 notice reports that the Matthew Shair 2021 Irrevocable Trust intends to sell 1,650 shares of Nuvalent Class A common stock through J.P. Morgan Securities on Nasdaq, with an aggregate market value of 166,125. The notice states that 67,271,461 Class A shares were outstanding, providing context for the planned sale’s relative size. The shares to be sold were originally acquired by grant and transferred to the trust on 07/13/2021. The filing also lists several prior sales by the same trust over the past three months.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Nuvalent (NUVL) Form 144 disclose about upcoming share sales?

The filing discloses that the Matthew Shair 2021 Irrevocable Trust plans to sell 1,650 Nuvalent Class A shares under Rule 144. The planned sale, through J.P. Morgan Securities on Nasdaq, has an aggregate market value of $166,125 based on the figures reported.

Who is selling Nuvalent (NUVL) shares and how were they acquired?

The seller is the Matthew Shair 2021 Irrevocable Trust, for whose account the securities will be sold. The 1,650 Class A shares were acquired via a grant and transferred to the trust on July 13, 2021, according to the transaction details provided.

How large is the Nuvalent (NUVL) Form 144 sale compared with shares outstanding?

The notice covers 1,650 Class A shares, with an aggregate market value of $166,125. It reports 67,271,461 Class A shares outstanding, indicating the planned sale represents a very small fraction of the company’s total outstanding equity at the referenced time.

Which broker and exchange are involved in the Nuvalent (NUVL) Form 144 sale?

The planned Rule 144 sale will be executed through J.P. Morgan Securities LLC as broker. The Class A common stock is expected to be sold on Nasdaq, which is the named securities exchange in the Form 144 disclosure for this transaction.

What prior Nuvalent (NUVL) share sales by the trust are listed in the filing?

The filing lists several past three-month sales by the Matthew Shair 2021 Irrevocable Trust, including multiple 5,850- and 1,650-share Class A transactions. Reported gross proceeds for these trades range from about $170,561 to $639,807 across dates in November 2025 through January 2026.

What representation does the seller make in the Nuvalent (NUVL) Form 144?

The person for whose account the shares are to be sold represents by signing that they do not know any undisclosed material adverse information about the issuer’s current or prospective operations, consistent with Rule 144 requirements stated in the notice’s certification language.
Nuvalent, Inc.

NASDAQ:NUVL

NUVL Rankings

NUVL Latest News

NUVL Latest SEC Filings

NUVL Stock Data

8.08B
74.29M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE